Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology
2026 final full text in Europe PMC XML · Peer-reviewed
What this source contributed
Records in this release that cite this source. A record can cite several sources.
Results
Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.
Claims
Statements this source supports, each with where in the source it was checked.
- Baseline: Assess somatic small-variant oncogenicity: Baseline ClinGen/CGC/VICC rules (OncoVI) and SIFT (uc-clinical-20260930-source-oncovi: Methods (IF-ELSE implementation of the points-based SOP); somatic-oncogenicity-20261009-source-chen2020: Table 1 (SIFT position-specific scoring matrix) and Introduction (SIFT widely used in cancer research))
- Configuration identity: OncoVI 2026 publication configuration: Configuration of Oncogenicity Variant Interpreter (OncoVI) (Methods and OncoVI implementation)
- Historical Erlangen MTB protein-function interpretation: facets.method_types: Facets: method types ["conventional_pipeline"] (OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP)
- Oncogenicity Variant Interpreter (OncoVI): facets.method_types: Facets: method types ["conventional_pipeline"] (OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP)
- OncoVI 2026 publication configuration: facets.method_types: Facets: method types ["conventional_pipeline"] (OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP)
- Published study membership: OncoVI three-class assessment: ClinVar April 2025 oncogenicity assertions: Part of OncoVI 2026 oncogenicity evaluation study (Results and Figures2–4; ClinVar assessment)
- Published study membership: OncoVI three-class assessment: Erlangen MTB variants: Part of OncoVI 2026 oncogenicity evaluation study (Results and Figures2–4; ClinVar assessment)
- Published study membership: OncoVI three-class assessment: Guideline SOP variants: Part of OncoVI 2026 oncogenicity evaluation study (Results and Figures2–4; ClinVar assessment)
- Published study membership: OncoVI three-class assessment: MTB selected expert reassessment: Part of OncoVI 2026 oncogenicity evaluation study (Results and Figures2–4; ClinVar assessment)
- Relevance of OncoVI three-class assessment: ClinVar April 2025 oncogenicity assertions to "Assess somatic small-variant oncogenicity": Assessed by OncoVI three-class assessment: ClinVar April 2025 oncogenicity assertions (uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6)
- Relevance of OncoVI three-class assessment: Erlangen MTB variants to "Assess somatic small-variant oncogenicity": Assessed by OncoVI three-class assessment: Erlangen MTB variants (uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6)
- Relevance of OncoVI three-class assessment: Guideline SOP variants to "Assess somatic small-variant oncogenicity": Assessed by OncoVI three-class assessment: Guideline SOP variants (uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6)
- Relevance of OncoVI three-class assessment: MTB selected expert reassessment to "Assess somatic small-variant oncogenicity": Assessed by OncoVI three-class assessment: MTB selected expert reassessment (uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6)
Models, benchmarks and other records
Methods (1)
Configurations (3)
Benchmarks (1)
Protocols (4)
Datasets (4)
Baselines (2)
Evaluations (5)
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
17 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Artifact retrieval endpoint https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13269341/fullTextXML Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact retrieved at 2026-09-30T21:23:41Z Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact SHA-256 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2 Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact url https://pmc.ncbi.nlm.nih.gov/articles/PMC13269341/ Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Doi 10.1016/j.jmoldx.2026.03.004 Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Publication status peer_reviewed Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Retrieved at 2026-09-30T21:43:37Z Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Url https://pmc.ncbi.nlm.nih.gov/articles/PMC13269341/ Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Version 2026 final full text in Europe PMC XML Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Description Primary source inspected for the scoped extraction; automated review does not establish replication. Source metadata | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
Primary source inspected for the scoped extraction; automated review does not establish replication.
Technical metadata and extraction receipts
Stable ID: uc-clinical-20260930-source-oncovi
- areas
- dna-genomes
- contexts
- clinical_research
- url
- https://pmc.ncbi.nlm.nih.gov/articles/PMC13269341/
- retrieved at
- 2026-09-30T21:43:37Z
- version
- 2026 final full text in Europe PMC XML
- publication status
- peer_reviewed
- artifact retrieval endpoint
- https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13269341/fullTextXML
- doi
- 10.1016/j.jmoldx.2026.03.004
- artifact sha256
- 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2
- artifact url
- https://pmc.ncbi.nlm.nih.gov/articles/PMC13269341/
- artifact retrieved at
- 2026-09-30T21:23:41Z